|
NIH-CDC Meeting on Molecular and Phylodynamic Approaches to HIV Prevention
|
Meeting/ Workshop
|
CDC
|
NIAID
|
Attendees at the NIH-CDC meeting on molecular and phylodynamic approaches to HIV prevention discussed joint NIH-interests in HIV phylodynamic analysis of transmission networks. Emphasis on scientific gaps and opportunities for both agencies. Discussions on continued communication towards future collaborations.
|
|
NIH-CDC-IDSA Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, OD/DPCPSI/OAR
|
The National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and the Centers for Disease Control and Prevention (CDC) have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunodeficiency virus (HIV). These guidelines are intended for clinicians and other health-care providers who care for HIV-infected adults and adolescents, including pregnant women; they complement companion guidelines for treatment of OIs among HIV-infected children and previously published guidelines for prevention of OIs in these populations.
|
|
NIH-FDA Clinical Trial Protocol Template Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
The NIH-FDA Clinical Trial Protocol Template Working Group was established to facilitate collaboration and cooperation between NIH research program directors and FDA, to help develop protocol templates to facilitate transfer of NIH-supported research into FDA''s regulatory processes.
|
|
NIH-FDA Communications Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
The NIH-FDA communications working group was established to facilitate collaboration and cooperation between NIH research program directors and FDA, to help ensure that NIH grantees will produce evidence that will meet FDA specifications for regulatory action and/or approval for drugs and medical devices.
|
|
NIH-FDA Interagency Clinical Outcome Assessments (ICOA) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research. Leveraging the unique strengths, knowledge, and resources at both the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH), the objectives of the ICOA WG are: 1) To increase communication between the relevant groups at FDA and the many separate efforts at NIH to advance measurement science by exchanging information about specific COA projects of common interest, thereby improving the knowledge base for COA development; 2) To clarify and disseminate information about the regulatory processes for evaluation of medical product development tools; 3) To foster appropriate interagency scientific efforts to generate evidence toward the development and potential qualification of novel COAs; and 4) To leverage public and private efforts toward consensus and standards development in this area. The ICOA WG is composed of representatives and selected senior staff of each agency
|
|
NIH-FDA Joint Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/OSP, NCATS, NCCIH, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS
|
The NIH-FDA Joint Leadership Council work together to help ensure that regulatory considerations form an integral component of biomedical research planning and the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a strong partnership and to leverage the strengths of each agency toward this common goal.
|
|
NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Prevention of Maternal Child HIV Transmission (PMTCT) Implementation Science Alliance
|
Other
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/DPCPSI/OAR, OD/DPCPSI/ORWH
|
Using the NIH/President’s Emergency Plan for AIDS Relief (PEPFAR) Collaboration for Advancing Implementation Science in Prevention of Maternal Child HIV Transmission (PMTCT) request for applications (RFA) as a platform, the NIH-PEPFAR PMTCT Implementation Science Alliance promoted collaboration between implementation science researchers and program implementers and policy makers on the ground. Basing this work on actual implementation research issues rather than hypothetical examples, this project provided a unique function, serving as the “connective tissue” over 2 years for the PIs and collaborators and program implementers on the ground. In this capacity, the Alliance created a forum for the network of grantees, PMTCT implementers, and policymakers on a regular basis enabling cross-fertilization of ideas, insights and experiences as the research and the field progress.The Alliance has successfully enabled cross-fertilization of ideas, insights and experiences as the research progressed and was able to bridge the gap between PMTCT research and program/policy. The Alliance produced six publications, including a supplement entitled, "Advancing Implementation Science in Prevention of Maternal-Child HIV Transmission" published in JAIDS.
|
|
Northwest Portland Tribal Registry Project
|
Resource Development
|
IHS
|
NCI
|
Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon.
|
|
Nutrition Research Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
NIDDK, CC, CIT, CSR, FIC, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/DPCPSI/ODP, OD/DPCPSI/ODS
|
Nutrition Research Coordinating Committee (NRCC) operates as an NIH-wide forum to review, stimulate, and encourage the support of nutrition research and training to better define the role of nutrition in the promotion and maintenance of health and in the prevention and treatment of disease. The NRCC also plays a key role in the development of nutrition research policy at the NIH. The goal of the NRCC is to review, stimulate, and encourage the necessary support of nutrition research and training and to define the role of nutrition in health promotion and disease prevention and management. NCC membership includes a representative and alternate from the 20 NIH Institutes and 7 Centers. In addition, offices and agencies within the Department of Health and Human Services (HHS), U.S. Department of Agriculture (USDA), and the Department of Defense (DOD) have also appointed liaison representatives to the Committee. The NRCC meets monthly to provide an open forum for members to report on current and future nutrition research, policy activities, and research funding and training opportunities.
|
|
Office for Human Research Protections/Office of Extramural Research Training Initiative
|
Meeting/ Workshop
|
OS
|
OD/OER
|
The National Institutes of Health collaborated with the Office for Human Research Protections to provide comprehensive training at both NIH Regional Meetings for the extramural community.
|